Biophytis (formerly known as Institut Biophytis) is a biotechnology company focused on the development of drug candidates for the treatment of age-related diseases. It develops therapeutics to restore the muscular and visual functions in diseases such as Sarcopenia and Duchenne muscular dystrophy (DMD). Its therapeutic approach is aimed at targeting and activating key biological resilience pathways that can protect against and counteract the effects of the multiple biological and environmental stresses, including inflammatory, oxidative and metabolic stresses that lead to age-related diseases.